Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies. 

Biotechnology

Education

Genesis Therapeutics

Genesis Therapeutics' headquarters in South San Francisco, CA, United States

This department oversees the development and execution of strategic initiatives and business programs.

Program Management

This department focuses on scientific research and innovation to advance product development and enhance technological capabilities.

Research and Development

This department focuses on advancing machine learning methodologies and developing innovative algorithms and models.

Machine Learning Research

This department focuses on research and development in computational chemistry methodologies and applications.

Computational Chemistry

This department focuses on designing, developing, and maintaining software applications and systems.

Software Development

This department focuses on advanced research and development in computer-aided design and drafting.

CADD Research

This department focuses on the research and development of chemical compounds for therapeutic use.

People (4)

Jobs (0)

Other teams

Research and Development

Machine Learning Research

Computational Chemistry

Software Development

CADD Research

Medicinal Chemistry